NA Proactive news snapshot: Todos Medical, Kontrol Energy, PyroGenesis Canada, 1933 Industries UPDATE ...

Todos Medical Ltd (OTCQB:TOMDF) announced Friday that the US Food and Drug Administration has added the company’s COVID-19 qPCR detection test kit to its Notified List under the Emergency Use Authorization (EUA) program. The FDA’s decision allows the Israeli company to commercially launch its branded test kits in the US. Todos is required to submit an EUA application to the FDA within 15 days of submission of the notification. Todos said its test is currently authorized to use only the QuantStudio 12Flex Instrument as a platform to perform the RT-PCR assay. It is estimated that there are more than 1,000 QuantStudio 12Flex Instrument installations in the US. The company anticipates first shipments of test kits for existing CLIA laboratory clients to begin next week. Kontrol Energy Corp (CSE:KNR) (OTCQB:KNRLF) saw its stock take off on Friday after the firm revealed its BioCloud technology could detect the presence of coronavirus (COVID-19) in the air.The Toronto-based firm received positive lab results for BioCloud testing against the live virus that causes COVID-19 following two successful tests against the dormant SARS-CoV-2 virus, it said in a statement. PyroGenesis Canada Inc (CVE:PYR) (OTCQB:PYRNF) CEO Peter Pascali defended the company’s sales pipeline on Friday after the company confirmed it was on track with its current and prospective projects. The Montreal-based company, which designs and manufactures high-tech plasma products, was responding to a drop in its share price on Friday, which prompted a brief halt in trading before resuming on Friday afternoon around C$4.72. In a statement, Pascali told shareholders that there was an indication that recent comments from a fund manager doubting the firm’s ability to sell more than one or two torches within the next few months led to the decline. 1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) announced Friday it has set up distribution of its Canna Hemp line of wellness products with CBD Plus, the largest and most trusted supplier of CBD products across the US. The Vancouver, British Columbia-based company said its wholly owned subsidiary Infused MFG signed a master service and supply agreement with MCV Enterprises LLC, an Oklahoma company doing business as CBD Plus and CBD Plus USA for the marketing and sale of Canna Hemp products in CBD Plus corporate-owned and franchisee brick and mortar retail stores. The one-year agreement includes a 45-day trial period, effective immediately. CBD Plus is focused in the Midwest and Southern US, with over 120 locations in Texas, Oklahoma, Kansas, Arkansas, Tennessee, Georgia, Florida, North Carolina, and Maryland. Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) has named longtime clinical research executive Jean-Francois Boily its new CFO, the company announced Friday, effective September 14. Boily brings more than 15 years of industry experience to Tetra, including executive positions in clinical research organizations, the core of the company’s research and development activities. He has worked at several pharmaceutical companies and built an excellent reputation in developing financial relationships, raising capital, satisfying financial obligations, ensuring record control, overseeing mergers and acquisitions and more, the company said. Boily replaces Sabino Di Paola, who joined Tetra in 2019 and was instrumental in its graduation from the TSXV to the TSX. Cabral Gold Inc (CVE:CBR) (OTCPINK:CBGZF) said Friday it is “unaware of any material change” that could account for a recent increase in trading activity after the company’s stock was halted on Friday morning by the TSX Venture Exchange. The junior resource company and is engaged in the identification, exploration and development of mineral properties, with a primary focus on gold properties located in Brazil. Its shares will resume trading on Friday afternoon. Vuzix Corporation (NASDAQ: VUZI) announced Friday that its M-Series smart glasses now support Oculogx, a provider of omnichannel order fulfillment software designed for increased productivity.  Oculogx recently launched its suite of out-of-the-box products that make order fulfillment faster and more accurate. The Oculogx solution is suitable for storefronts, warehouses and retail stores and includes support for wearables to enable hands-free order picking, real-time order management, analytics, and a mobile fulfillment application. The Oculogx suite consists of Ocx One, Outline and Portal, New York-based Vuzix noted. NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29), a dominant player in the red-hot augmented reality space for e-commerce, video conferencing and virtual events, revealed on Friday that it is now an approved Microsoft partner, creating an "enormous" new business opportunity for the company. The company said the partnership provides access to the Azure Marketplace so that InfernoAR can be sold directly through the Marketplace. NexTech said it is also working to become a part of the Microsoft cross-sell program, where Microsoft sales reps will sell InfernoAR and be incentivized to do so as they will win Azure sales credits whenever they make an InfernoAR product sale. Lucky Minerals Inc (CVE:LKY) (OTCMKTS:LKMNF), the Ecuador-focused explorer, updated investors on work at its Fortuna property, where another target zone for gold has been identified. A system of quartz veins has been discovered at the Fortuna 3 and 4 concessions at the 55,000-hectare royalty-free property. Chesapeake Financial Shares Inc (OTCQX:CPKF), which operates as the bank holding company for Chesapeake Bank, said on Thursday that the community bank has implemented Texas-based Q2 Holdings Inc’s (NYSE:QTWO) “best-in-class” commercial banking technology to improve the banking experiences for its business customers. Founded in 1900, Chesapeake Bank is primarily a lender to small businesses. It is headquartered in Kilmarnock, Virginia and operates 15 community banks in the Northern Neck, Middle Peninsula, Williamsburg and Richmond region. Chesapeake Bank, which is presiding on a digital transformation, said it treated its digital evaluation as “an opportunity” to hone its “go-to-market strategy,” focusing their digital investment dollars in the areas that are “most important” to the company’s growth. Acasti Pharma Inc.(NASDAQ:ACST) (CVE:ACST) has announced that Jean-François Boily, its vice-president, Finance has tendered his resignation to pursue other business opportunities. The company said Boily will assist with a smooth and orderly transition of his functions and the group expects that its existing internal finance team currently in place will be able to assume his functions going forward. Acasti also said it has filed and mailed the information circular and management proxy statement for its upcoming annual and special meeting of shareholders to be held on September 30, 2020 at 1.00pm Eastern Time, which will be held online only, via a virtual meeting portal. In addition, the group said its the board of directors has resolved to change the record date for the meeting as indicated in the circular for the purpose of determining the company’s shareholders which are entitled to receive notice of and to vote at the meeting from August 26, 2020 to September 8, 2020.  Subject to the approvals of the TSX Venture Exchange and of the shareholders at the meeting, the board is also resolved to amend the group's stock option plan for purposes of maintaining a fixed stock option and equity incentive pool that may be granted under both plans, collectively representing 15% of the shares currently outstanding for the two plans combined. Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced Friday the access details for CEO Dwight Egan's presentation on the company's significant growth, profitability, and future objectives. The Utah company's in-vitro Logix Smart Coronavirus Disease 2019 (COVID-19) test kits are available in nearly 50 countries. Egan will make his presentation at HC Wainwright's 22nd Annual Global Investment Conference on September 14 at 10 ET.